| Mrs Robyn A Schleifman, CRNA | |
|
9127 W Russell Rd Ste 110, Las Vegas, NV 89148 | |
| (702) 878-0070 | |
| (702) 209-2064 |
| Full Name | Mrs Robyn A Schleifman |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 19 Years |
| Location | 9127 W Russell Rd Ste 110, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194788786 | NPI | - | NPPES |
| 1194788786 | Medicaid | NV | |
| 86878U | Other | TX | BLUE CROSS PROVIDER ID |
| P00452396 | Other | TX | RR MEDICARE |
| 188132801 | Medicaid | TX | |
| 913200530A | Medicaid | GA | |
| 188132802 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Medical Center Of Stockton | Stockton, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Services Of San Joaquin Pc | 4082754056 | 72 |
News Archive
Medical Facilities Corporation, today reported its financial results for the three and nine-month periods ended September 30, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.
ETH scientists have developed a special protective membrane made of cellulose that significantly reduces the build-up of fibrotic tissue around cardiac pacemaker implants, as reported in the current issue of the journal Biomaterials.
Scientists from The University of Manchester say a naturally occurring chemical found in soy could prove to be an effective new treatment for a fatal genetic disease that affects children.
Telling someone to "act your age" is another way of asking him or her to behave better. Age, however, does not always bring improvements.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
› Verified 8 days ago
| Entity Name | Resource Anesthesiology Assoc Of California, A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083746259 PECOS PAC ID: 6608974647 Enrollment ID: O20070614000336 |
News Archive
Medical Facilities Corporation, today reported its financial results for the three and nine-month periods ended September 30, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.
ETH scientists have developed a special protective membrane made of cellulose that significantly reduces the build-up of fibrotic tissue around cardiac pacemaker implants, as reported in the current issue of the journal Biomaterials.
Scientists from The University of Manchester say a naturally occurring chemical found in soy could prove to be an effective new treatment for a fatal genetic disease that affects children.
Telling someone to "act your age" is another way of asking him or her to behave better. Age, however, does not always bring improvements.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
› Verified 8 days ago
| Entity Name | Anesthesia Services Of San Joaquin Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366778227 PECOS PAC ID: 4082754056 Enrollment ID: O20091223000174 |
News Archive
Medical Facilities Corporation, today reported its financial results for the three and nine-month periods ended September 30, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.
ETH scientists have developed a special protective membrane made of cellulose that significantly reduces the build-up of fibrotic tissue around cardiac pacemaker implants, as reported in the current issue of the journal Biomaterials.
Scientists from The University of Manchester say a naturally occurring chemical found in soy could prove to be an effective new treatment for a fatal genetic disease that affects children.
Telling someone to "act your age" is another way of asking him or her to behave better. Age, however, does not always bring improvements.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
› Verified 8 days ago
| Entity Name | Advanced Anesthesia Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720543762 PECOS PAC ID: 4880936145 Enrollment ID: O20190507001500 |
News Archive
Medical Facilities Corporation, today reported its financial results for the three and nine-month periods ended September 30, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.
ETH scientists have developed a special protective membrane made of cellulose that significantly reduces the build-up of fibrotic tissue around cardiac pacemaker implants, as reported in the current issue of the journal Biomaterials.
Scientists from The University of Manchester say a naturally occurring chemical found in soy could prove to be an effective new treatment for a fatal genetic disease that affects children.
Telling someone to "act your age" is another way of asking him or her to behave better. Age, however, does not always bring improvements.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
› Verified 8 days ago
| Entity Name | Valley Regional Anesthesia Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578272415 PECOS PAC ID: 3870964323 Enrollment ID: O20230120001928 |
News Archive
Medical Facilities Corporation, today reported its financial results for the three and nine-month periods ended September 30, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.
ETH scientists have developed a special protective membrane made of cellulose that significantly reduces the build-up of fibrotic tissue around cardiac pacemaker implants, as reported in the current issue of the journal Biomaterials.
Scientists from The University of Manchester say a naturally occurring chemical found in soy could prove to be an effective new treatment for a fatal genetic disease that affects children.
Telling someone to "act your age" is another way of asking him or her to behave better. Age, however, does not always bring improvements.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Robyn A Schleifman, CRNA 9127 W Russell Rd Ste 110, Las Vegas, NV 89148-1253 Ph: (702) 878-0070 | Mrs Robyn A Schleifman, CRNA 9127 W Russell Rd Ste 110, Las Vegas, NV 89148 Ph: (702) 878-0070 |
News Archive
Medical Facilities Corporation, today reported its financial results for the three and nine-month periods ended September 30, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.
ETH scientists have developed a special protective membrane made of cellulose that significantly reduces the build-up of fibrotic tissue around cardiac pacemaker implants, as reported in the current issue of the journal Biomaterials.
Scientists from The University of Manchester say a naturally occurring chemical found in soy could prove to be an effective new treatment for a fatal genetic disease that affects children.
Telling someone to "act your age" is another way of asking him or her to behave better. Age, however, does not always bring improvements.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
› Verified 8 days ago